GlaxoSmithKline Pharmaceuticals Limited (BOM: 500660)

GlaxoSmithKline Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	477,369	329,173	224,319	281,714	244,012	210,953
Market Cap Growth	86.28%	46.74%	-20.37%	15.45%	15.67%	-4.20%
Enterprise Value	458,988	313,334	211,499	270,099	237,483	201,694
Last Close Price	2817.90	1919.12	1278.71	1512.34	1285.01	1082.19
PE Ratio	74.60	55.11	35.47	15.12	60.78	196.70
PS Ratio	13.62	9.53	6.90	8.59	8.34	6.54
PB Ratio	26.85	18.52	12.88	10.58	16.51	11.59
P/FCF Ratio	-	59.76	50.96	36.30	45.72	63.05
P/OCF Ratio	-	56.56	46.33	34.75	42.22	43.01
EV/Sales Ratio	13.09	9.07	6.50	8.24	8.12	6.26
EV/EBITDA Ratio	46.59	35.58	26.83	36.36	41.42	31.37
EV/EBIT Ratio	49.59	37.35	28.26	38.65	45.71	34.36
EV/FCF Ratio	-	56.89	48.05	34.80	44.50	60.28
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Debt / EBITDA Ratio	0.02	0.02	0.02	0.03	0.06	0.06
Debt / FCF Ratio	-	0.03	0.04	0.03	0.06	0.13
Asset Turnover	-	1.00	0.82	0.85	0.94	0.92
Inventory Turnover	-	2.75	2.62	2.55	2.49	2.73
Quick Ratio	-	1.45	1.50	1.83	1.02	1.17
Current Ratio	-	1.84	1.88	2.18	1.63	1.74
Return on Equity (ROE)	-	33.53%	27.59%	18.39%	17.42%	4.71%
Return on Assets (ROA)	-	15.24%	11.75%	11.27%	10.40%	10.41%
Return on Capital (ROIC)	32.56%	29.52%	21.07%	20.82%	19.24%	18.33%
Earnings Yield	1.34%	1.79%	2.72%	6.02%	1.47%	0.44%
FCF Yield	1.67%	1.96%	2.75%	2.19%	1.59%
Dividend Yield	1.14%	1.67%	2.50%	1.98%	2.33%	1.85%
Payout Ratio	0.00%	91.80%	249.80%	29.89%	189.04%	363.51%
Total Shareholder Return	1.10%	1.67%	2.50%	1.98%	2.33%	1.85%

Source: S&P Capital IQ. Standard template. Financial Sources.